DARBITOP 40MG

Darbitop 40mcg injection contains Darbepoetin Alfa as its active ingredient. This antineoplastic medication falls under the category of hematopoietic growth factors. It is prescribed for treating anemia (reduced RBC count) in individuals suffering from chronic kidney disease. Additionally, it is indicated for managing chemotherapy-induced anemia in patients with specific cancer types. Common symptoms of anemia include fatigue, weakness, and shortness of breath.

Do not use Darbitop 40mcg injection if you are allergic to Darbepoetin alfa or any of its components, and if you have uncontrolled hypertension. Notify your doctor if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or a latex allergy, or if you have hepatitis C. Also, inform your physician if you are pregnant or nursing.

If you experience severe headaches, dizziness, drowsiness, confusion, vision problems, nausea, vomiting, or seizures after administering Darbitop 40mcg injection, contact your physician immediately and seek medical assistance. The most frequently reported side effects of this medication include hypertension, shortness of breath, leg swelling, and cough.